GenMark Diagnostics, Inc.
DelistedCIK 1487371fmd_0GQC2FJZ1ECE8CCWHYRGX3Z0J9Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2009 to Dec 31, 2020, 44 periods
Latest annual · FY2020
Millions- Total revenues
- 172
- Gross profit
- 68
- Operating income
- (11)
- Net income
- (19)
- Free cash flow
- (12)
Latest quarter · Q4 FY2020
Millions- Total revenues
- 50
- Gross profit
- 19
- Operating income
- (2)
- Net income
- (4)
- Free cash flow
- (10)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2017 to FY2020
- +48.4%
- Revenue, 5 yearsFY2015 to FY2020
- +34.2%
- Net income, 5 yearsFY2015 to FY2020
- n/m
GenMark Diagnostics, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2020 | FY2019 | Change | Source |
|---|---|---|---|---|
| Revenue | $171.6 million | $88 million | +94.9% | 10-K 2021-02-25 · proof |
| Gross profit | $67.9 million | $28.6 million | +137.5% | 10-K 2021-02-25 · proof |
| Operating income | -$11.1 million | -$41.8 million | 10-K 2021-02-25 · proof | |
| Net income | -$18.6 million | -$47.4 million | 10-K 2021-02-25 · proof | |
| Cash from operating activities | $6.1 million | -$34.9 million | 10-K 2021-02-25 · proof | |
| Free cash flow | -$11.6 million | -$37 million | 10-K 2021-02-25 · proof | |
| Total assets | $223.5 million | $111.5 million | +100.5% | 10-K 2021-02-25 · proof |
| Total liabilities | $129.3 million | $99.3 million | +30.2% | 10-K 2021-02-25 · proof |
| Cash and cash equivalents | $40.6 million | $44.4 million | -8.5% | 10-K 2021-02-25 · proof |
- What was GenMark Diagnostics, Inc.'s revenue in fiscal 2020?
- GenMark Diagnostics, Inc. reported revenue of $171.6 million for fiscal 2020 (the year ended Dec 31, 2020), against $88 million the year before (+94.9%). Source: the 10-K filed with the SEC on Feb 25, 2021. SEC
- What was GenMark Diagnostics, Inc.'s gross profit in fiscal 2020?
- GenMark Diagnostics, Inc. reported gross profit of $67.9 million for fiscal 2020 (the year ended Dec 31, 2020), against $28.6 million the year before (+137.5%). Source: the 10-K filed with the SEC on Feb 25, 2021. SEC
- What was GenMark Diagnostics, Inc.'s operating income in fiscal 2020?
- GenMark Diagnostics, Inc. reported operating income of -$11.1 million for fiscal 2020 (the year ended Dec 31, 2020), against -$41.8 million the year before. Source: the 10-K filed with the SEC on Feb 25, 2021. SEC
- What was GenMark Diagnostics, Inc.'s net income in fiscal 2020?
- GenMark Diagnostics, Inc. reported net income of -$18.6 million for fiscal 2020 (the year ended Dec 31, 2020), against -$47.4 million the year before. Source: the 10-K filed with the SEC on Feb 25, 2021. SEC
- What was GenMark Diagnostics, Inc.'s cash from operating activities in fiscal 2020?
- GenMark Diagnostics, Inc. reported cash from operating activities of $6.1 million for fiscal 2020 (the year ended Dec 31, 2020), against -$34.9 million the year before. Source: the 10-K filed with the SEC on Feb 25, 2021. SEC
- What was GenMark Diagnostics, Inc.'s free cash flow in fiscal 2020?
- GenMark Diagnostics, Inc. reported free cash flow of -$11.6 million for fiscal 2020 (the year ended Dec 31, 2020), against -$37 million the year before. Source: the 10-K filed with the SEC on Feb 25, 2021. SEC
- What are GenMark Diagnostics, Inc.'s total assets?
- As of Dec 31, 2020, GenMark Diagnostics, Inc. reported total assets of $223.5 million, against $111.5 million a year earlier (+100.5%). Source: the 10-K filed with the SEC on Feb 25, 2021. SEC
- What are GenMark Diagnostics, Inc.'s total liabilities?
- As of Dec 31, 2020, GenMark Diagnostics, Inc. reported total liabilities of $129.3 million, against $99.3 million a year earlier (+30.2%). Source: the 10-K filed with the SEC on Feb 25, 2021. SEC
- What are GenMark Diagnostics, Inc.'s cash and cash equivalents?
- As of Dec 31, 2020, GenMark Diagnostics, Inc. reported cash and cash equivalents of $40.6 million, against $44.4 million a year earlier (-8.5%). Source: the 10-K filed with the SEC on Feb 25, 2021. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1487371&period_type=annual&limit=5"Information only, not investment advice.